Acesso livre
Acesso livre

Vacinas

Respostas às 7 questões mais urgentes sobre a vacina contra varíola dos macacos – “Temos opções seguras e efetivas – porém, com poucos suprimentos.”

18 Jul, 2022 | 13:35h

7 of your most pressing monkeypox vaccine questions, answered – Vox

Conteúdos relacionados:

How contagious is monkeypox—and should you get a vaccine? Here’s the latest. – National Geographic

Prevention and Treatment of Monkeypox – Drugs

Monkeypox soars in Europe, with more than 4,000 cases – CIDRAP

No room for complacency – World Health Organization

Multi-country monkeypox outbreak: situation update – World Health Organization

Monkeypox Genital Lesions – New England Journal of Medicine

Monkeypox: Africa CDC Demands Equal Treatment in Global Allocation of Limited Vaccine Doses – Health Policy Watch

Monkeypox vaccination begins — can the global outbreaks be contained? – Nature

Incubation period for monkeypox: Estimates from the Netherlands.

‘Discriminatory and stigmatizing’: Scientists push to rename monkeypox viruses – STAT

Rename monkeypox strains to remove geographic stigma, researchers say – Science

Clinical management and infection prevention and control for monkeypox: Interim rapid response guidance, 10 June 2022 – World Health Organization

2022 Monkeypox and Orthopoxvirus Outbreak Global Map – Centers for Disease Control and Prevention

As monkeypox threat grows, scientists debate best vaccine strategy – Science

Monkeypox is a new global threat. African scientists know what the world is up against – Science

WHO Experts Emphasize ‘Window of Opportunity’ to Control Monkeypox Spread as Cases Outside Africa Double Again – Health Policy Watch

Genetic data indicate at least two separate monkeypox outbreaks underway, suggesting wider spread – STAT

Experts highlight sexual aspect of monkeypox spread – CIDRAP

What to Know About Monkeypox – JAMA

Multi-country monkeypox outbreak in non-endemic countries: Update – World Health Organization

Principles for monkeypox control in the UK: 4 nations consensus statement – UK Health Security Agency

Monkeypox outbreaks: 4 key questions researchers have – Nature

Study reports first use of antivirals in monkeypox patients – Lancet

Surveillance, case investigation and contact tracing for Monkeypox – World Health Organization

Laboratory testing for the monkeypox virus: Interim guidance – World Health Organization

A Novel International Monkeypox Outbreak – Annals of Internal Medicine

EU health agency warns monkeypox could become endemic in Europe if outbreak continues – STAT

Monkeypox cases increase across Europe, North America – CIDRAP

Multi-country monkeypox outbreak in non-endemic countries – World Health Organization

Monkeypox goes global: why scientists are on alert – Nature

Monkeypox: What do we know about the outbreaks in Europe and North America? – The BMJ

Seven Confirmed Monkeypox Cases in UK Includes Sexually Transmitted Cluster – STAT

What is monkeypox? A microbiologist explains what’s known about this smallpox cousin – The Conversation

Monkeypox: Time to worry or one to ignore? – BBC

UK, Spain, Portugal report more monkeypox cases – CIDRAP

U.S. monkeypox case reported, as Spain, Portugal report infections in growing outbreak – STAT

Monkeypox – United Kingdom of Great Britain and Northern Ireland – World Health Organization

Monkeypox cases confirmed in England – latest updates – UK Health Security Agency

Seven Confirmed Monkeypox Cases in UK Includes Sexually Transmitted Cluster – Health Policy Watch

European outbreak of monkeypox: what you need to know – The Conversation

Rare monkeypox outbreak in U.K., Europe and U.S.: What is it and should we worry – NPR

Monkeypox cases under investigation in Canada as outbreak spreads in Europe, U.S. – CBC News

 


FDA autoriza o uso emergencial da vacina Novavax contra COVID-19.

18 Jul, 2022 | 13:01h

Coronavirus (COVID-19) Update: FDA Authorizes Emergency Use of Novavax COVID-19 Vaccine, Adjuvanted – U.S. Food & Drug Administration

Comentários:

FDA authorizes Novavax Covid vaccine, in hopes the traditional shot will convince holdouts – STAT

US regulators OK new COVID-19 shot option from Novavax – Associated Press

 


Estudo de coorte de abrangência nacional | Segurança dos esquemas de vacinação primária heteróloga e reforços com vacinas ChAdOx1-S e BNT162b2 ou mRNA-1273.

18 Jul, 2022 | 12:54h

Safety of heterologous primary and booster schedules with ChAdOx1-S and BNT162b2 or mRNA-1273 vaccines: nationwide cohort study – The BMJ

 


European Medicines Agency recomenda reforço de vacina contra COVID em pessoas com mais de 60 anos.

12 Jul, 2022 | 11:54h

European Medicines Agency Recommends Second COVID Booster for People Over 60 – as WHO Ponders Guidance – Health Policy Watch

 


Estudo de caso controle e teste negativo | Efetividade da 4ª dose de vacina de mRNA contra Covid-19 causada pela variante Ômicron entre residentes de instituições de longa permanência em Ontário, Canadá.

8 Jul, 2022 | 11:30h

Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study – The BMJ

 


Revisão | O momento de hesitação da vacina.

7 Jul, 2022 | 12:21h

The Vaccine-Hesitant Moment – New England Journal of Medicine


Riscos específicos relacionados a idade e sexo para miocardite e pericardite após vacinação contra Covid-19 com vacinas de RNA mensageiro.

7 Jul, 2022 | 12:20h

Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines – Nature Communications


Opinião | FDA: não faça nenhum movimento para mudar a composição da vacina contra Covid-19.

5 Jul, 2022 | 11:59h

FDA: Don’t rush a move to change the Covid-19 vaccine composition – STAT


Estudo de coorte | Efetividade das vacinas Pfizer, Moderna e AstraZeneca contra desfechos graves de Covid-19 em um cenário de vacinação em massa de abrangência nacional.

4 Jul, 2022 | 12:16h

Effectiveness of BNT162b2, mRNA-1273, and ChAdOx1-S vaccines against severe covid-19 outcomes in a nationwide mass vaccination setting: cohort study – BMJ Medicine

 

Comentário no Twitter

 


Diretriz provisória da OMS sobre o uso de vacinas contra COVID-19 atualizadas para as variantes.

21 Jun, 2022 | 13:12h

Interim statement on decision-making considerations for the use of variant updated COVID-19 vaccines – World Health Organization

Ver também: Interim statement on the composition of current COVID-19 vaccines – World Health Organization

 

Comentário no Twitter (fio – clique para saber mais)

 


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.